These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29651569)

  • 61.
    Umbricht CA; Benešová M; Schmid RM; Türler A; Schibli R; van der Meulen NP; Müller C
    EJNMMI Res; 2017 Dec; 7(1):9. PubMed ID: 28102507
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Development of [
    Hooijman EL; Chalashkan Y; Ling SW; Kahyargil FF; Segbers M; Bruchertseifer F; Morgenstern A; Seimbille Y; Koolen SLW; Brabander T; de Blois E
    Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34068206
    [TBL] [Abstract][Full Text] [Related]  

  • 63. 68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies.
    Weineisen M; Schottelius M; Simecek J; Baum RP; Yildiz A; Beykan S; Kulkarni HR; Lassmann M; Klette I; Eiber M; Schwaiger M; Wester HJ
    J Nucl Med; 2015 Aug; 56(8):1169-76. PubMed ID: 26089548
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Estimation of Whole Body Radiation Exposure to Nuclear Medicine Personnel During Synthesis of
    Arora G; Mishra R; Kumar P; Yadav M; Ballal S; Bal C; Damle NA
    Indian J Nucl Med; 2017; 32(2):89-92. PubMed ID: 28533634
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Individualisation of radiation protection recommendations for patients treated with [
    Monserrat Fuertes T; Santos Zorrozua B; Rodeño Ortiz de Zarate E; Peinado Montes MÁ; Vigil Díaz C; Mínguez Gabiña P
    EJNMMI Phys; 2023 Sep; 10(1):50. PubMed ID: 37665476
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Benefits of adopting good radiation practices in reducing the whole body radiation dose to the nuclear medicine personnel during (18)F-fluorodeoxyglucose positron emission tomography/computed tomography imaging.
    Verma S; Kheruka SC; Maurya AK; Kumar N; Gambhir S; Kumari S
    Indian J Nucl Med; 2016; 31(1):27-30. PubMed ID: 26917890
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Influence of sampling schedules on [
    Rinscheid A; Kletting P; Eiber M; Beer AJ; Glatting G
    EJNMMI Phys; 2020 Jun; 7(1):41. PubMed ID: 32556844
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Radiation levels outside a patient undergoing
    Li H; Liu H; Zhang W; Lin X; Li Z; Zhuo W
    J Radiol Prot; 2024 Apr; 44(2):. PubMed ID: 38537256
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Quality control of [
    Aalbersberg EA; Cao TT; Geluk-Jonker MM; Hendrikx JJMA
    EJNMMI Radiopharm Chem; 2022 Sep; 7(1):24. PubMed ID: 36166155
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Radiation safety considerations for the use of radium-224-calciumcarbonate-microparticles in patients with peritoneal metastasis.
    Grønningsæter SR; Blakkisrud J; Selboe S; Revheim ME; Bruland ØS; Bønsdorff TB; Larsen SG; Stokke C
    Front Med (Lausanne); 2023; 10():1058914. PubMed ID: 36844217
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Technical note: Quantifying radionuclide residues in hospital wastewater: A case study on [
    Kupitz D; Einspänner E; Wissel H; Volk M; Hohn A; Kreissl MC; Grosser OS
    Med Phys; 2024 Oct; 51(10):7574-7579. PubMed ID: 38922963
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lutetium-177 Therapy in Italy: Environmental Impact Assessment in Anticipation of Its Widespread Use in Prostate Cancer Treatment.
    Brusa A; Campi F; Cavatorta C; Porta AA; Viganò S
    Health Phys; 2024 Sep; ():. PubMed ID: 39330935
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Assessment of radiation level and potential risk to public living around major hospitals in central and western Bangladesh.
    Rahman MM; Rahman MS; Khan MHR; Yeasmin S
    Heliyon; 2023 Sep; 9(9):e19774. PubMed ID: 37810098
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Importance of bladder radioactivity for radiation safety in nuclear medicine.
    Gültekin SS; Sahmaran T
    Mol Imaging Radionucl Ther; 2013 Dec; 22(3):94-7. PubMed ID: 24416625
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Estimation of effective half life of clearance of radioactive Iodine (I) in patients treated for hyperthyroidism and carcinoma thyroid.
    Ravichandran R; Binukumar J; Saadi AA
    Indian J Nucl Med; 2010 Apr; 25(2):49-52. PubMed ID: 21188063
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Feasibility of safe outpatient treatment in pediatric patients following intraventricular radioimmunotherapy with 131I-omburtamab for leptomeningeal disease.
    Prasad K; Serencsits BE; Chu BP; Dauer LT; Donzelli M; Basu E; Kramer K; Pandit-Taskar N
    Res Sq; 2024 Feb; ():. PubMed ID: 38464207
    [TBL] [Abstract][Full Text] [Related]  

  • 77. SUBSTANTIAL EXTERNAL DOSE RATE VARIABILITY OBSERVED IN A COHORT OF LU-177 PATIENTS INDEPENDENT OF BMI AND SEX.
    Bellamy M; Chu B; Serencsits B; Quinn B; Prasad K; Altamirano J; Williamson M; Miodownik D; Abrahams N; Chen F; Bierman D; Wutkowski M; Dauer L
    Radiat Prot Dosimetry; 2022 Oct; 198(19):1476-1482. PubMed ID: 36138119
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Radioactive iodine (I-131) therapy isolation rooms: Introduction of lead glass window on the wall for patient comfort and better ambience.
    Al Aamri M; Ravichandran R; Al Balushi N
    World J Nucl Med; 2019; 18(1):42-44. PubMed ID: 30774545
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Correction to: Influence of dosimetry method on bone lesion absorbed dose estimates in PSMA therapy: application to mCRPC patients receiving Lu-177-PSMA-I&T.
    Brosch-Lenz J; Uribe C; Gosewisch A; Kaiser L; Todica A; Ilhan H; Gildehaus FJ; Bartenstein P; Rahmim A; Celler A; Ziegler S; Böning G
    EJNMMI Phys; 2021 Apr; 8(1):36. PubMed ID: 33847807
    [No Abstract]   [Full Text] [Related]  

  • 80. Estimation of the Release Time from Isolation for Patients with Differentiated Thyroid Cancer Treated with High-dose I-131.
    Lee JH; Park SG
    Nucl Med Mol Imaging; 2010 Dec; 44(4):241-5. PubMed ID: 24899959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.